{"result": "(\"entity\"<|>SPAIN<|>GEO<|>Spain is a country in Southwestern Europe known for its diverse culture and significant research in diabetes prevalence and management.)\n##\n(\"entity\"<|>HOSPITAL DISCHARGE RECORDS<|>EVENT<|>Hospital discharge records are documents that summarize a patient's hospital stay, including diagnoses and treatments, and may under-report diabetes prevalence among inpatients.)\n##\n(\"entity\"<|>AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS<|>ORGANIZATION<|>The American Association of Clinical Endocrinologists is a professional organization that focuses on the clinical practice of endocrinology, including diabetes management.)\n##\n(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association is a leading organization in the United States that advocates for diabetes research, education, and management.)\n##\n(\"entity\"<|>INPATIENT GLUCOSE CONTROL<|>EVENT<|>Inpatient glucose control refers to the management of blood sugar levels in hospitalized patients, which is critical for those with diabetes.)\n##\n(\"entity\"<|>COMMUNITY-ACQUIRED PNEUMONIA<|>EVENT<|>Community-acquired pneumonia is a type of pneumonia acquired outside of a hospital setting, which can have implications for patients with diabetes.)\n##\n(\"entity\"<|>NUTRITION AREA OF THE SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>ORGANIZATION<|>This group focuses on the nutritional aspects of endocrinology and diabetes management in Spain.)\n##\n(\"entity\"<|>TOTAL PARENTERAL NUTRITION<|>EVENT<|>Total parenteral nutrition is a medical method of feeding that bypasses the gastrointestinal tract, often used for patients who cannot eat normally, including those with diabetes.)\n##\n(\"entity\"<|>MULTICENTER STUDY<|>EVENT<|>A multicenter study is a research study conducted at several different locations, which can provide broader insights into diabetes management practices.)\n##\n(\"entity\"<|>DIABETES RESEARCH<|>EVENT<|>Diabetes research encompasses various studies aimed at understanding diabetes, its causes, and effective management strategies.)\n##\n(\"entity\"<|>HYPERGLYCEMIA<|>EVENT<|>Hyperglycemia refers to high blood sugar levels, which is a common concern for patients with diabetes and can lead to serious health complications.)\n##\n(\"entity\"<|>GLYCEMIC CONTROL<|>EVENT<|>Glycemic control refers to the management of blood sugar levels in individuals with diabetes, crucial for preventing complications.)\n##\n(\"entity\"<|>POLIFARMACIA<|>EVENT<|>Polifarmacia refers to the use of multiple medications by a patient, which can complicate diabetes management and increase the risk of adverse effects.)\n##\n(\"entity\"<|>CORTICOTHERAPY<|>EVENT<|>Corticotherapy involves the use of corticosteroids for treatment, which can affect blood sugar levels and complicate diabetes management.)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: de\n    pacientes con NE presentaban glucemia mayor de 200 mg/dl31 . En Residencia Geri√°trica\n    los pacientes con NE y demencia presentaban HbA1c > 7% en el 50% de los casos, de\n    los cuales la mitad de los casos no estaban diagnosticados de diabetes32 .\n             Por otra parte, en ocasiones puede ser dif√≠cil el control gluc√©mico de los pacientes\n    con NE y diabetes o hiperglucemia de estr√©s. Las razones pueden ser m√∫ltiples:\n    tanto organizativas por la ausencia de protocolos universales de insulinizaci√≥n para\n    un paciente muy heterog√©neo y miedo a la aparici√≥n de hipoglucemias severas en un\n    paciente fr√°gil, como por la severidad de la hiperglucemia en un paciente agudo con\n    polifarmacia y corticoterapia33 .\n             Existen m√∫ltiples documentos de recomendaciones sobre el uso de la nutrici√≥n\n    enteral en el paciente diab√©tico. Recomendamos la lectura de las dos revisiones publi-\n    cadas por grupos espa√±oles34,35 .\n28\n---\nBibliograf√≠a\n1.  F. Soriguer, A. Goday, A. Bosch-Comas, E. Bordi√∫, A. Calle-Pascual, R. Carmena, R. Casamitjana, L.\nCasta√±o, C. Castell, M. Catal√°, E. Delgado,              J. Franch, S. Gaztambide, J Girb√©s, R. Gomis, G. Guti√©rrez,\nA. L√≥pez Alba, M. T. Mart√≠nez-Larrad, E. Men√©ndez, I. Mora-Peces, E. Ortega, G. Pascual-Manich, G. Ro-\njo-Mart√≠nez, M. Serrano-Rios, S. Vald√©s, J. A. V√°zquez, J. Vendrell. Prevalence of diabetes mellitus and\nimpaired glucose regulation in Spain. Diabetolog√≠a 2011;10.1007/s00125-011-2336-9.\n\n\n\n2. Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose control: a glyce-\nmic survey of 126 U.S. hospitals. J Hosp Med. 2009;4(9):E7-E14.\n\n\n\n3. OMS online - http://www.who.int/es/\n\n\n\n4. Carral F, Olveira G, Aguilar M, Ortego J, Gavil√°n I, Dom√©nech I, Escobar L. Hospital discharge records\nunder-report the prevalence of diabetes in inpatients. Diabetes Res Clin Pract. 2003;59(2):145-51.\n\n\n\n5. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists\nand American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Diabetes\nCare. 2009;32(6):1119-1131.\n\n\n\n6. Moss SE, Klein R, Klein BE. Risk factors for hospitalization in people                         with diabetes. Arch Intern\nMed. 1999;159(17):2053.\n\n\n\n7. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Ramirez-Perez C. Complications associated with enteral\nnutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001;10:482‚Äì490.\n\n\n\n8. OLVEIRA 2015: (Study Group Of Hyperglycemia In Parenteral Nutrition Nutrition Area Of The Spanish\nSociety Of Endocrinology And Nutrition SEEN, Olveira G, Tapia MJ, Oc√≥n J, Cabrejas-G√≥mez C, Balleste-\nros-Pomar MD, Vidal-Casariego A, Arraiza-Irigoyen C, Olivares J, Conde-Garc√≠a MC, Garc√≠a-Manzanares\n√Å, Botella-Romero F, Qu√≠lez-Toboso RP, Cabrerizo L, Mat√≠a P, Chicharro L, Burgos R, Pujante P, Ferrer\nM, Zugasti A, Petrina E, Manj√≥n L, Di√©guez M, Carrera MJ, Vila-Bundo A, Urgel√©s JR, Arag√≥n-Valera C,\nS√°nchez-Vilar O, Bret√≥n I, Garc√≠a-Peris P, Mu√±oz-Garach A, M√°rquez E, Del Olmo D, Pereira JL, Tous\nMC. Prevalence of diabetes, prediabetes, and stress hyperglycemia: insulin therapy and metabolic\ncontrol in patients on total parenteral nutrition (prospective multicenter study). Endocr Pract. 2015\nJan;21(1):59-67).\n\n\n\n9. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hypergly-\ncemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia.\nDiabetes Care. 2005 Apr;28(4):810-5.\n\n\n\n10. Olveira-Fuster G, Olvera-M√°rquez P, Carral-Sanlaureano F, Gonz√°lez-Romero S, Aguilar-Diosdado\nM, Soriguer-Escofet F. Excess hospitalizations, hospital days, and inpatient costs among\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>RESIDENCIA GERI√ÅTRICA<|>ORGANIZATION<|>Residencia Geri√°trica is a facility where elderly patients with neurocognitive disorders are cared for, particularly those with diabetes and dementia.)\n##\n(\"entity\"<|>F. SORIGUER<|>PERSON<|>F. Soriguer is an author involved in diabetes research, contributing to studies on the prevalence of diabetes mellitus in Spain.)\n##\n(\"entity\"<|>A. GODAY<|>PERSON<|>A. Goday is a researcher who co-authored studies on diabetes prevalence and management in Spain.)\n##\n(\"entity\"<|>A. BOSCH-COMAS<|>PERSON<|>A. Bosch-Comas is a contributor to diabetes research, focusing on glucose regulation and its implications.)\n##\n(\"entity\"<|>E. BORDI√ö<|>PERSON<|>E. Bordi√∫ is a researcher who has published work on diabetes and its complications.)\n##\n(\"entity\"<|>A. CALLE-PASCUAL<|>PERSON<|>A. Calle-Pascual is involved in diabetes research, particularly in the context of Spain.)\n##\n(\"entity\"<|>R. CARMENA<|>PERSON<|>R. Carmena is a researcher contributing to the understanding of diabetes management.)\n##\n(\"entity\"<|>R. CASAMITJANA<|>PERSON<|>R. Casamitjana is a co-author of studies on diabetes prevalence and management.)\n##\n(\"entity\"<|>L. CASTA√ëO<|>PERSON<|>L. Casta√±o is a researcher involved in diabetes studies in Spain.)\n##\n(\"entity\"<|>C. CASTELL<|>PERSON<|>C. Castell is a contributor to diabetes research literature.)\n##\n(\"entity\"<|>M. CATAL√Å<|>PERSON<|>M. Catal√° is a researcher who has published work on diabetes management.)\n##\n(\"entity\"<|>E. DELGADO<|>PERSON<|>E. Delgado is involved in diabetes research, focusing on clinical practices.)\n##\n(\"entity\"<|>J. FRANCH<|>PERSON<|>J. Franch is a researcher contributing to studies on diabetes prevalence.)\n##\n(\"entity\"<|>S. GAZTAMBIDE<|>PERSON<|>S. Gaztambide is a co-author of diabetes research studies.)\n##\n(\"entity\"<|>J. GIRB√âS<|>PERSON<|>J. Girb√©s is involved in diabetes research, particularly in Spain.)\n##\n(\"entity\"<|>R. GOMIS<|>PERSON<|>R. Gomis is a researcher contributing to diabetes studies.)\n##\n(\"entity\"<|>G. GUTI√âRREZ<|>PERSON<|>G. Guti√©rrez is a co-author of studies on diabetes prevalence and management.)\n##\n(\"entity\"<|>A. L√ìPEZ ALBA<|>PERSON<|>A. L√≥pez Alba is involved in diabetes research in Spain.)\n##\n(\"entity\"<|>M. T. MART√çNEZ-LARRAD<|>PERSON<|>M. T. Mart√≠nez-Larrad is a researcher contributing to diabetes studies.)\n##\n(\"entity\"<|>E. MEN√âNDEZ<|>PERSON<|>E. Men√©ndez is involved in diabetes research, focusing on clinical implications.)\n##\n(\"entity\"<|>I. MORA-PECES<|>PERSON<|>I. Mora-Peces is a researcher contributing to diabetes studies.)\n##\n(\"entity\"<|>E. ORTEGA<|>PERSON<|>E. Ortega is involved in diabetes research, particularly in Spain.)\n##\n(\"entity\"<|>G. PASCUAL-MANICH<|>PERSON<|>G. Pascual-Manich is a researcher contributing to diabetes studies.)\n##\n(\"entity\"<|>G. ROJO-MART√çNEZ<|>PERSON<|>G. Rojo-Mart√≠nez is involved in diabetes research, focusing on prevalence and management.)\n##\n(\"entity\"<|>M. SERRANO-RIOS<|>PERSON<|>M. Serrano-Rios is a researcher contributing to diabetes studies.)\n##\n(\"entity\"<|>S. VALD√âS<|>PERSON<|>S. Vald√©s is involved in diabetes research in Spain.)\n##\n(\"entity\"<|>J. A. V√ÅZQUEZ<|>PERSON<|>J. A. V√°zquez is a researcher contributing to diabetes studies.)\n##\n(\"entity\"<|>J. VENDRELL<|>PERSON<|>J. Vendrell is involved in diabetes research, particularly in Spain.)\n##\n(\"entity\"<|>OMS<|>ORGANIZATION<|>The World Health Organization (OMS) is a specialized agency of the United Nations responsible for international public health.)\n##\n(\"entity\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>EVENT<|>Diabetes Research and Clinical Practice is a journal that publishes research on diabetes management and clinical practices.)\n##\n(\"entity\"<|>DIABETES CARE<|>EVENT<|>Diabetes Care is a journal that publishes research on diabetes care and management.)\n##\n(\"entity\"<|>J HOSP MED<|>EVENT<|>Journal of Hospital Medicine publishes research related to hospital medicine, including studies on diabetes management.)\n##\n(\"entity\"<|>ARCH INTERN MED<|>EVENT<|>Archives of Internal Medicine is a journal that publishes research on internal medicine, including diabetes-related studies.)\n##\n(\"entity\"<|>J CLIN NURS<|>EVENT<|>Journal of Clinical Nursing publishes research on nursing practices, including those related to diabetes care.)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>F. SORIGUER<|>F. Soriguer's research may inform practices at Residencia Geri√°trica regarding diabetes management in elderly patients<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>A. GODAY<|>A. Goday's research may influence diabetes care protocols at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>A. BOSCH-COMAS<|>A. Bosch-Comas's findings could impact diabetes management strategies at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>E. BORDI√ö<|>E. Bordi√∫'s research may guide diabetes care practices at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>A. CALLE-PASCUAL<|>A. Calle-Pascual's studies could inform diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>R. CARMENA<|>R. Carmena's research may influence diabetes care at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>R. CASAMITJANA<|>R. Casamitjana's findings could impact diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>L. CASTA√ëO<|>L. Casta√±o's research may guide diabetes care practices at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>C. CASTELL<|>C. Castell's studies could inform diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>M. CATAL√Å<|>M. Catal√°'s research may influence diabetes care at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>E. DELGADO<|>E. Delgado's findings could impact diabetes management strategies at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>J. FRANCH<|>J. Franch's research may guide diabetes care practices at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>S. GAZTAMBIDE<|>S. Gaztambide's studies could inform diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>J. GIRB√âS<|>J. Girb√©s's research may influence diabetes care at Residencia GERI√ÅTRICA<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>R. GOMIS<|>R. Gomis's findings could impact diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>G. GUTI√âRREZ<|>G. Guti√©rrez's research may guide diabetes care practices at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>A. L√ìPEZ ALBA<|>A. L√≥pez Alba's studies could inform diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>M. T. MART√çNEZ-LARRAD<|>M. T. Mart√≠nez-Larrad's research may influence diabetes care at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>E. MEN√âNDEZ<|>E. Men√©ndez's findings could impact diabetes management strategies at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>I. MORA-PECES<|>I. Mora-Peces's research may guide diabetes care practices at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>E. ORTEGA<|>E. Ortega's studies could inform diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>G. PASCUAL-MANICH<|>G. Pascual-Manich's research may influence diabetes care at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>G. ROJO-MART√çNEZ<|>G. Rojo-Mart√≠nez's findings could impact diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>M. SERRANO-RIOS<|>M. Serrano-Rios's research may guide diabetes care practices at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>S. VALD√âS<|>S. Vald√©s's studies could inform diabetes management at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>J. A. V√ÅZQUEZ<|>J. A. V√°zquez's research may influence diabetes care at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>RESIDENCIA GERI√ÅTRICA<|>J. VENDRELL<|>J. Vendrell's findings could impact diabetes management strategies at Residencia Geri√°trica<|>7)\n##\n(\"relationship\"<|>OMS<|>F. SORIGUER<|>F. Soriguer's research may align with OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>A. GODAY<|>A. Goday's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>A. BOSCH-COMAS<|>A. Bosch-Comas's findings could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>E. BORDI√ö<|>E. Bordi√∫'s research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>A. CALLE-PASCUAL<|>A. Calle-Pascual's studies could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>R. CARMENA<|>R. Carmena's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>R. CASAMITJANA<|>R. Casamitjana's findings could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>L. CASTA√ëO<|>L. Casta√±o's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>C. CASTELL<|>C. Castell's studies could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>M. CATAL√Å<|>M. Catal√°'s research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>E. DELGADO<|>E. Delgado's findings could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>J. FRANCH<|>J. Franch's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>S. GAZTAMBIDE<|>S. Gaztambide's studies could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>J. GIRB√âS<|>J. Girb√©s's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>R. GOMIS<|>R. Gomis's findings could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>G. GUTI√âRREZ<|>G. Guti√©rrez's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>A. L√ìPEZ ALBA<|>A. L√≥pez Alba's studies could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>M. T. MART√çNEZ-LARRAD<|>M. T. Mart√≠nez-Larrad's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>E. MEN√âNDEZ<|>E. Men√©ndez's findings could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>I. MORA-PECES<|>I. Mora-Peces's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>E. ORTEGA<|>E. Ortega's studies could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>G. PASCUAL-MANICH<|>G. Pascual-Manich's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>G. ROJO-MART√çNEZ<|>G. Rojo-Mart√≠nez's findings could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>M. SERRANO-RIOS<|>M. Serrano-Rios's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>S. VALD√âS<|>S. Vald√©s's studies could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>OMS<|>J. A. V√ÅZQUEZ<|>J. A. V√°zquez's research may align with OMS recommendations on diabetes care<|>5)\n##\n(\"relationship\"<|>OMS<|>J. VENDRELL<|>J. Vendrell's findings could support OMS guidelines on diabetes management<|>5)\n##\n(\"relationship\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>F. SORIGUER<|>F. Soriguer's research may be published in Diabetes Research and Clinical Practice<|>8)\n##\n(\"relationship\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>A. GODAY<|>A. Goday's research may be published in Diabetes Research and Clinical Practice<|>8)\n##\n(\"relationship\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>A. BOSCH-COMAS<|>A. Bosch-Comas's findings could be published in Diabetes Research and Clinical Practice<|>8)\n##\n(\"relationship\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>E. BORDI√ö<|>E. Bordi√∫'s research may be published in Diabetes Research and Clinical Practice<|>8)\n##\n(\"relationship\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>A. CALLE-PASCUAL<|>A. Calle-Pascual's studies could be published in Diabetes Research and Clinical Practice<|>8)\n##\n(\"relationship\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>R. CARMENA<|>R. Carmena's research may be published in Diabetes Research and Clinical Practice<|>8)\n##\n(\"relationship\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>R. CASAMITJANA<|>R. Casamitjana's findings could be published in Diabetes Research and Clinical Practice<|>8)\n##\n(\"relationship\"<|>DIABETES RESEARCH AND CLINICAL PRACTICE<|>L. CASTA√ëO<|>L. Casta√±o's research may"}]}